To investigate the effects of the TLR7/8 agonist in combination with classical fractionated photon radiotherapy in vivo, we induced tumor homografts by subcutaneous implantation of CT26 tumor fragments in immunocompetent BALB/c mice. Here, TLR7 is linked to neoplasm.